Concentrix (NASDAQ:CNXC) Trading Down 10.4% – What’s Next?

Shares of Concentrix Corporation (NASDAQ:CNXC) fell 10.4% during mid-day trading on Wednesday . The stock traded as low as $34.96 and last traded at $35.2050. 737,221 shares traded hands during trading, a decline of 40% from the average session volume of 1,221,354 shares. The stock had previously closed at $39.27.

Analysts Set New Price Targets

A number of research firms recently weighed in on CNXC. Weiss Ratings downgraded Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research report on Thursday, January 29th. Wall Street Zen lowered shares of Concentrix from a “buy” rating to a “hold” rating in a report on Saturday, January 17th. Barrington Research reaffirmed an “outperform” rating and set a $62.00 target price on shares of Concentrix in a report on Monday, January 12th. Finally, Robert W. Baird set a $52.00 target price on shares of Concentrix in a research report on Wednesday, January 14th. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $63.75.

Concentrix Stock Down 11.5%

The company has a market capitalization of $2.14 billion, a P/E ratio of -1.67, a price-to-earnings-growth ratio of 0.41 and a beta of 0.50. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.67. The stock’s fifty day moving average is $40.48 and its 200 day moving average is $44.20.

Concentrix (NASDAQ:CNXC) last released its quarterly earnings data on Tuesday, January 13th. The company reported $2.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.93 by $0.02. The firm had revenue of $2.55 billion for the quarter, compared to analysts’ expectations of $2.54 billion. Concentrix had a negative net margin of 13.02% and a positive return on equity of 16.91%. The company’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $3.26 earnings per share. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. Research analysts predict that Concentrix Corporation will post 10.11 EPS for the current fiscal year.

Concentrix Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, February 10th. Investors of record on Friday, January 30th were issued a $0.36 dividend. The ex-dividend date was Friday, January 30th. This represents a $1.44 annualized dividend and a yield of 4.1%. Concentrix’s payout ratio is -6.91%.

Insider Buying and Selling

In related news, CEO Christopher A. Caldwell bought 1,000 shares of the company’s stock in a transaction dated Thursday, January 29th. The stock was purchased at an average cost of $37.07 per share, with a total value of $37,070.00. Following the transaction, the chief executive officer owned 362,075 shares in the company, valued at approximately $13,422,120.25. This trade represents a 0.28% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 3.20% of the company’s stock.

Institutional Trading of Concentrix

Several large investors have recently bought and sold shares of CNXC. Huntington National Bank grew its holdings in shares of Concentrix by 6,011.1% during the 3rd quarter. Huntington National Bank now owns 550 shares of the company’s stock worth $25,000 after acquiring an additional 541 shares during the period. Quent Capital LLC bought a new stake in shares of Concentrix during the third quarter valued at approximately $29,000. Larson Financial Group LLC grew its stake in Concentrix by 224.9% in the third quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock worth $32,000 after purchasing an additional 479 shares during the period. Geneos Wealth Management Inc. raised its holdings in Concentrix by 532.7% in the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after purchasing an additional 522 shares in the last quarter. Finally, Rothschild Investment LLC lifted its position in Concentrix by 14,980.0% during the third quarter. Rothschild Investment LLC now owns 754 shares of the company’s stock valued at $35,000 after buying an additional 749 shares during the period. 90.34% of the stock is owned by institutional investors.

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.